World's Best Scientists 2026 revealed!
Douglas V. Faller

Douglas V. Faller

D-Index & Metrics

Biology and Biochemistry

D-Index
79
Citations
23299
World Ranking
4295
National Ranking
279

Douglas V. Faller publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Douglas V. Faller sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 346 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Douglas V. Faller D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas V. Faller sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 79 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Douglas V. Faller is affiliated with Takeda (Japan) in Japan and has a substantial body of research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work encompasses a significant focus on specialized subfields including Molecular Biology, Hematology, Oncology, Genetics, and Pulmonary and Respiratory Medicine.

Their research covers a range of topics, notably acute myeloid leukemia, protein degradation and inhibitors, histone deacetylase inhibitors, ubiquitin and proteasome pathways, amyloidosis with emphasis on diagnosis, treatment, and outcomes, myeloproliferative neoplasms, and multiple myeloma research and treatments.

Frequent coauthors collaborating with Douglas V. Faller include Robert J. Fram, Lionel Adès, Mikkael A. Sekeres, Farhad Sedarati, and María Diez-Campelo.

Notable recent publications by Douglas V. Faller include:

  • Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML, 2022, Blood Advances
  • Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML, 2021, Leukemia
  • Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer, 2020, British Journal of Cancer
  • Global epidemiology of amyloid light-chain amyloidosis, 2022, Orphanet Journal of Rare Diseases
  • A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis, 2021, Leukemia

Douglas V. Faller's work is frequently published in venues such as Blood, Journal of Clinical Oncology, Leukemia, Gynecologic Oncology, and Clinical Lymphoma Myeloma & Leukemia. The scientist has contributed to Blood with 10 publications and has multiple works appearing in the Journal of Clinical Oncology (5), Leukemia (3), Gynecologic Oncology (3), and Clinical Lymphoma Myeloma & Leukemia (3).

Best Publications

  • A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

    Nancy C. Andrews;Douglas V. Faller

  • Hypoxia induces endothelin gene expression and secretion in cultured human endothelium.

    S Kourembanas;P A Marsden;L P McQuillan;D V Faller

  • Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.

    S Kourembanas;L P McQuillan;G K Leung;D V Faller

  • A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders

    S. P. Perrine;G. D. Ginder;D. V. Faller;G. H. Dover

  • Neutral amino acids in the brain: changes in response to food ingestion.

    John D. Fernstrom;Douglas V. Faller

  • Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells.

    S Kourembanas;R L Hannan;D V Faller

  • Endothelial cell responses to hypoxic stress.

    Douglas V Faller

  • SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis

    V Byles;L Zhu;J D Lovaas;L K Chmilewski

  • Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.

    George F. Atweh;Millicent Sutton;Imad Nassif;Vassiliki Boosalis

  • A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

    Susan P. Perrine;Olivier Hermine;Trudy Small;Felipe Suarez

  • Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor.

    C. A. Sieff;Schickwann Tsai;D. V. Faller

  • Characterization and mapping of RNase T1-resistant oligonucleotides derived from the genomes of Akv and MCF murine leukemia viruses.

    Jean Rommelaere;Douglas V. Faller;Nancy Hopkins

  • Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients

    Raymond L. Comenzo;Evan Vosburgh;Robert W. Simms;Peter Bergethon

  • Delay in the fetal globin switch in infants of diabetic mothers.

    Susan P. Perrine;Michael F. Greene;Douglas V. Faller

  • You bet-cha: a novel family of transcriptional regulators.

    Florence B;Faller Dv

  • RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F.

    Gerald V. Denis;Cyrus Vaziri;Ning Guo;Douglas V. Faller

  • Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?

    James S. Chen;Douglas V. Faller;Remco A. Spanjaard

  • Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific.

    M. Amin Arnaout;Lewis L. Lanier;Douglas V. Faller

  • Medical hyperspectral imaging to facilitate residual tumor identification during surgery.

    Svetlana V Panasyuk;Shi Yang;Douglas V Faller;Duyen Ngo

  • Butyrate histone deacetylase inhibitors.

    Kosta Steliou;Michael S. Boosalis;Susan P. Perrine;José Sangerman

Frequent Co-Authors

Steven J. Burakoff
Steven J. Burakoff Icahn School of Medicine at Mount Sinai
Robert M. Williams
Robert M. Williams Colorado State University
Cyrus Vaziri
Cyrus Vaziri University of North Carolina at Chapel Hill
Stella Kourembanas
Stella Kourembanas Boston Children's Hospital
Barbara A. Miller
Barbara A. Miller Pennsylvania State University
Colin A. Sieff
Colin A. Sieff Harvard University
Yuet Wai Kan
Yuet Wai Kan University of California, San Francisco
David H.K. Chui
David H.K. Chui Boston University
Jean Rommelaere
Jean Rommelaere German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to diverse healthcare and science careers. Today, many students look for flexible, online options to gain specialized training or advance their qualifications from home. Understanding the related degree pathways can help you find the right fit for your ambitions.

For registered nurses seeking advancement, an rn to bsn program offers a convenient route to greater clinical responsibility and leadership roles. If you're interested in nutrition and health, consider an online nutritionist degree that balances affordability with accredited coursework.

Advanced practice nurses can boost their qualifications with a 1 year post master's fnp online certificate, which is a fast track to become a Family Nurse Practitioner. Alternatively, science graduates and healthcare professionals might pursue a masters degree in healthcare management to prepare for dynamic leadership and administrative positions.

These varied online degrees can complement your background in Biology or Biochemistry, allowing you to specialize, advance, or pivot your career rapidly and cost-effectively.

Best Scientists Citing Douglas V. Faller

Trending Scientists

Recently Published Articles